- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Sustainable Track Record
U.S. Pharmaceuticals & Biotech Sustainable Track Record
Results
9
1 new
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
9 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MEDP | US$326.09 | -9.9% | 17.8% | US$9.8b | US$349.32 | PE27.7x | E10.9% | n/a | ||
CPRX | US$21.15 | -7.2% | 52.6% | US$2.6b | US$32.25 | PE17.7x | E17.5% | n/a | ||
A | US$128.57 | -4.3% | 3.7% | US$36.1b | US$150.11 | PE26.1x | E4.1% | 0.7% | ||
HALO | US$45.76 | -21.9% | 14.1% | US$5.7b | US$62.44 | PE14.8x | E21.1% | n/a | ||
PBYI | US$2.84 | -4.4% | -31.4% | US$134.5m | US$4.33 | PE6x | E-45.4% | n/a | ||
ETST New | US$0.16 | 27.9% | 113.0% | US$48.4m | n/a | PE21.3x | n/a | n/a | ||
MDXG | US$9.06 | 21.3% | 19.7% | US$1.4b | US$13.00 | PE16.8x | E-1.9% | n/a | ||
COLL | US$30.00 | -0.6% | 15.5% | US$959.4m | US$42.25 | PE10.9x | E22.0% | n/a | ||
AMPH | US$44.09 | -3.1% | -21.3% | US$2.1b | US$59.00 | PE13.4x | E13.6% | n/a |
Page 1 of 1